Nicola Fusco

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Nicola Fusco
Oct 18, 2024, 15:13 | Blog
Studies presented at MAP2024 showcase the potential of CTCs, exo-miRNA, cfRNA in Cancer Detection and Progression Prediction - ESMO
ESMO - European Society for Medical Oncology shared a post on LinkedIn: "Three studies presented at…
Sep 13, 2024, 14:38 | Blog
OncoInfluencers to Follow on Social Media: Dr. Nicola Fusco
We are excited to feature Dr. Nicola Fusco, a distinguished figure in the field of…
Aug 22, 2024, 04:53 | Insight
Angelo Dipasquale: 20 years of Circulating Tumor Cells and Liquid Biopsy in Solid Tumors
Angelo Dipasquale shared on LinkedIn: “20 years of Circulating Tumor Cells and Liquid Biopsy in…
Nov 24, 2023, 01:10 | Blog
Luis E. Raez: The ISLB23 a total success for our young society with more than 400 people from >20 countries attending!!
Luis E. Raez, made the following post on Twitter: "The ISLB23 a total success for…
Oct 21, 2023, 19:36 | Blog
Nicola Fusco: It has been a genuine pleasure to visit the Institute Gustave Roussy
Nicola Fusco shared a post on LinkedIn: “It has been a genuine pleasure to visit…
Oct 11, 2023, 22:05 | Insight
Nicola Fusco: Our article on "low-risk TNBC" has been included in Elsevier’s Breast Cancer Awareness Month article collection! 
Nicola Fusco, made the following post on LinkedIn: "Our article on "low-risk TNBC" has been…
Aug 18, 2023, 04:56 | Insight
Nicola Fusco: The assessment of PDL1 Combined Positive Score (CPS)≥10 in metastatic triple-negative breast cancer.
Nicola Fusco, an Associate Professor at the Department of Oncology and Hemato-Oncology at the University…
All: 7 Posts: 1 - 100
Special Coverage